SCHEMBL9988560

SCHEMBL9988560

COc1ccccc1-c1[c]cccc1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.52
CA2 P00918 3/20 0.52
TP53 P04637 2/20 0.52
TSHR P16473 1/20 0.52
ALDH1A1 P00352 6/20 0.46
HPGD P15428 4/20 0.46
KDM4E B2RXH2 3/20 0.46
HSD17B10 Q99714 3/20 0.46
CYP3A4 P08684 2/20 0.46
ALOX15 P16050 2/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
ALOX12 P18054 1/20 0.46
MAPK1 P28482 1/20 0.46
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
APP P05067 1/20 0.42
CA7 P43166 2/20 0.40
CA9 Q16790 2/20 0.40
CA12 O43570 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7370333 0.86 TP53 (0.52) CA1CA2TP53TSHRALDH1A1
SCHEMBL2372578 0.85 APP (0.47) CA1CA2TP53TSHRALDH1A1
SCHEMBL16720235 0.84 TP53 (0.42) CA1CA2TP53TSHRALDH1A1
SCHEMBL2027163 0.84 APP (0.46) CA1CA2TP53TSHRALDH1A1
SCHEMBL16719594 0.83 ERN1 (0.43) CA1CA2TP53TSHRALDH1A1
SCHEMBL5614523 0.81 APP (0.43) CA1CA2ALDH1A1HPGDMEN1
SCHEMBL16720303 0.80 HSP90AA1 (0.39) CA1CA2TP53TSHRALDH1A1
SCHEMBL2373478 0.79 SMN1; SMN2 (0.46) CA2ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL16719326 0.79 ALDH1A1 (0.40) ALDH1A1KDM4ECYP3A4MAPT
SCHEMBL16719971 0.79 DRD1 (0.41) CA1CA2TP53TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2397462-A2 Compounds, compositions and methods of treatment for heart failure Cytokinetics, Inc. (US) 2011-12-21 EP claimed
EP-3068758-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE The Wistar Institute Of Anatomy And Biology (US) 2016-09-21 EP disclosed
WO-2015073864-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE THE WISAR INSTITUTE OF ANATOMY AND BIOLOGY (US) 2015-05-21 WO disclosed